Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response MEng. F. Lucka Jurisprudence

Jurisprudence

anhand welcher Merkmale die Frauen ausgewählt und geschult wurden

auf die Aufstellung des Jahresabschlusses einzuwirken

Professor an der Universität von Kalifornien

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response MEng. F. Lucka JurisprudenceGenomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response provides the most comprehensive body of knowledge available on the role of genetic and genomic variation in the individualization of drug therapies in cancer patients. As a consequence of the intrinsic chromosomal and genetic instability of the tumor genome, it is generally believed that tailoring of chemotherapy in cancer tients might be achieved by molecular analysis